August 2026

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update

Vancouver, British Columbia and Rehovot, Israel – August 11, 2026 - BioHarvest Sciences Inc (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced results from the second quarter and six months of 2026.   Dr. Zaki Rakib, Chief Executive Officer of BioHarvest, stated, “We are extremely pleased to have signed a manufacturing agreement this […]

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update Read More »

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance

Vancouver, British Columbia and Rehovot, Israel- August 11, 2026 – BioHarvest Sciences Inc (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced an exclusive manufacturing and supply agreement that secures production of a rare, endangered, fragrance plant cell culture, extending terms of the original Agreement (“the Agreement”) with its

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance Read More »